ArticleCancer2023

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Mehmet Altan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.